EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ligand distances as key predictors of pathogenicity and function in NMDA receptors

Ludovica Montanucci iD, Tobias Brünger, Nisha Bhattarai, Christian M Boßelmann, Sukhan Kim, James P Allen, Jing Zhang, Chiara Klöckner, Ilona Krey, Piero Fariselli, Patrick May, Johannes R Lemke und 4 weitere

Human Molecular Genetics · 29.01.2025 · 34 (2) · 128-139

DOI: 10.1093/hmg/ddae156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 13.11.2024. Verfasst von Ludovica Montanucci und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, 1133 John Freeman Blvd, Houston, TX 77030…. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic variants in the genes GRIN1, GRIN2A, GRIN2B, and GRIN2D, which encode subunits of the N-methyl-D-aspartate receptor (NMDAR), have been associated with severe and heterogeneous neurologic and neurodevelopmental disorders, including early onset epilepsy, developmental and epileptic encephalopathy, intellectual disability, and autism spectrum disorders. Missense variants in these genes can result in gain or loss of the NMDAR function, requiring opposite therapeutic treatments. Computational methods that predict pathogenicity and molecular functional effects of missense variants are therefore crucial for therapeutic applications. We assembled 223 missense variants from patients, 631 control variants from the general population, and 160 missense variants characterized by electrophysiological readouts that show whether they can enhance or reduce the function of the receptor. This includes new functional data from 33 variants reported here, for the first time. By mapping these variants onto the NMDAR protein structures, we found that pathogenic/benign variants and variants that increase/decrease the channel function were distributed unevenly on the protein structure, with spatial proximity to ligands bound to the agonist and antagonist binding sites being a key predictive feature for both variant pathogenicity and molecular functional consequences. Leveraging distances from ligands, we developed two machine-learning based predictors for NMDA variants: a pathogenicity predictor which outperforms currently available predictors and the first molecular function (increase/decrease) predictor. Our findings can have direct application to patient care by improving diagnostic yield for genetic neurodevelopmental disorders and by guiding personalized treatment informed by the knowledge of the molecular disease mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, N-Methyl-D-AspartateHumansLigandsMutation, MissenseNeurodevelopmental DisordersBinding SitesEpilepsyNerve Tissue Proteins

Stichwörter der Autor:innen

GRIN genesGain-/Loss-of-functionMachine LearningNMDA receptor

Substanzen

Receptors, N-Methyl-D-AspartateLigandsNerve Tissue ProteinsGRIN1 protein, humanNR2B NMDA receptor

Autor:innen und Institutionen

  • Department of Neurology, McGovern Medical School, The University of Texas Health Science Center at Houston, 1133 John Freeman Blvd, Houston, TX 77030, United States.
  • Cologne Center for Genomics, University of Cologne, University Hospital Cologne, Weyertal 115b, Cologne 50937, Germany.
  • Epilepsy Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44106, United States.
  • Department of Pharmacology and Chemical Biology, Emory University School of Medicine, 100 Woodruff Circle, Atlanta, GA 30322, United States.
  • Center for Functional Evaluation of Rare Variants (CFERV), Emory University School of Medicine, 100 Woodruff Circle, Atlanta, GA 30322, United States.
  • Institute of Human Genetics, University of Leipzig Hospitals and Clinics, Philipp-Rosenthal-street 55, Leipzig 04103, Germany.

ORCID-Profile: Ludovica Montanucci, Stephen F Traynelis

Förderung

  • NICHD NIH HHS
  • NIA NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Montanucci, L., Brünger, T., Bhattarai, N., Boßelmann, C. M., Kim, S., Allen, J. P., Zhang, J., Klöckner, C., Krey, I., Fariselli, P., May, P., Lemke, J. R., Myers, S. J., Yuan, H., Traynelis, S. F., & Lal, D. (2025). Ligand distances as key predictors of pathogenicity and function in NMDA receptors. Human Molecular Genetics, 34(2), 128-139. https://doi.org/10.1093/hmg/ddae156

Vancouver

Montanucci L, Brünger T, Bhattarai N, Boßelmann CM, Kim S, Allen JP, et al. Ligand distances as key predictors of pathogenicity and function in NMDA receptors. Human Molecular Genetics. 2025;34(2):128-139. doi:10.1093/hmg/ddae156

BibTeX
@article{Montanucci2025,
  author = {Montanucci, Ludovica and Brünger, Tobias and Bhattarai, Nisha and Boßelmann, Christian M and Kim, Sukhan and Allen, James P and Zhang, Jing and Klöckner, Chiara and Krey, Ilona and Fariselli, Piero and May, Patrick and Lemke, Johannes R and Myers, Scott J and Yuan, Hongjie and Traynelis, Stephen F and Lal, Dennis},
  title = {Ligand distances as key predictors of pathogenicity and function in NMDA receptors},
  journal = {Human Molecular Genetics},
  year = {2025},
  volume = {34},
  number = {2},
  pages = {128--139},
  doi = {10.1093/hmg/ddae156}
}
Kostenlos starten →